Abstract
A potential transdermal application of progesterone was investigated. In vitro diffusion studies of the drug were performed. Investigations were carried out in order to examine if the addition of urea, pantothenol, or laurocapram can enhance the release rates from Eud (Eudragit NE 30 D) matrices. Pantothenol and urea increased the release 1.4- to 1.6-fold. The transdermal therapeutic system (TTS) containing 10% laurocapram delivered the highest release rates with a 2.8-fold enhancement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
